Estrogen and bone metabolism
- PMID: 8865143
- DOI: 10.1016/0378-5122(96)01015-8
Estrogen and bone metabolism
Abstract
Estrogen plays an important role in the growth and maturation of bone as well as in the regulation of bone turnover in adult bone. During bone growth estrogen is needed for proper closure of epiphyseal growth plates both in females and in males. Also in young skeleton estrogen deficiency leads to increased osteoclast formation and enhanced bone resorption. In menopause estrogen deficiency induces cancellous as well as cortical bone loss. Highly increased bone resorption in cancellous bone leads to general bone loss and destruction of local architecture because of penetrative resorption and microfractures. In cortical bone the first response of estrogen withdrawal is enhanced endocortical resorption. Later, also intracortical porosity increases. These lead to decreased bone mass, disturbed architecture and reduced bone strength. At cellular level in bone estrogen inhibits differentiation of osteoclasts thus decreasing their number and reducing the amount of active remodeling units. This effect is probably mediated through some cytokines, IL-1 and IL-6 being strongest candidates. Estrogen regulates the expression of IL-6 in bone marrow cells by a so far unknown mechanism. It is still uncertain if the effects of estrogen on osteoblasts is direct or is due to coupling phenomenon between bone formation to resorption.
Similar articles
-
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.Osteoporos Int. 2003;14 Suppl 3:S2-8. doi: 10.1007/s00198-002-1340-9. Epub 2003 Mar 19. Osteoporos Int. 2003. PMID: 12730770 Review.
-
Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone.J Bone Miner Res. 1997 Aug;12(8):1231-40. doi: 10.1359/jbmr.1997.12.8.1231. J Bone Miner Res. 1997. PMID: 9258753
-
Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.J Clin Invest. 1999 May 15;103(10):1409-18. doi: 10.1172/JCI4682. J Clin Invest. 1999. PMID: 10330423 Free PMC article.
-
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.J Bone Miner Res. 1996 Aug;11(8):1043-51. doi: 10.1002/jbmr.5650110802. J Bone Miner Res. 1996. PMID: 8854239 Review.
-
Prevention and treatment of osteoporosis with hormone replacement therapy.Int J Fertil Menopausal Stud. 1993;38 Suppl 1:45-54. Int J Fertil Menopausal Stud. 1993. PMID: 8499959 Review.
Cited by
-
The relationship between pregnancy and temporomandibular disorder (TMD) through diagnostic criteria for temporomandibular disorders (DC/TMD) axis II evaluation: a case-control cross-sectional study.BMC Oral Health. 2024 Mar 16;24(1):342. doi: 10.1186/s12903-024-04009-y. BMC Oral Health. 2024. PMID: 38493079 Free PMC article.
-
PMAIP1, a novel diagnostic and potential therapeutic biomarker in osteoporosis.Aging (Albany NY). 2024 Feb 16;16(4):3694-3715. doi: 10.18632/aging.205553. Epub 2024 Feb 16. Aging (Albany NY). 2024. PMID: 38372699 Free PMC article.
-
Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases.Front Immunol. 2024 Jan 30;15:1333993. doi: 10.3389/fimmu.2024.1333993. eCollection 2024. Front Immunol. 2024. PMID: 38352872 Free PMC article. Review.
-
Estradiol enhanced neuronal plasticity and ameliorated astrogliosis in human iPSC-derived neural models.Regen Ther. 2024 Jan 12;25:250-263. doi: 10.1016/j.reth.2023.12.018. eCollection 2024 Mar. Regen Ther. 2024. PMID: 38293585 Free PMC article.
-
Menopause Is More Than Just Loss of Fertility.Public Policy Aging Rep. 2023 Dec 10;33(4):113-119. doi: 10.1093/ppar/prad023. eCollection 2023. Public Policy Aging Rep. 2023. PMID: 38155935 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
